Invivyd Inc. (IVVD)

NASDAQ HEALTHCARE

$1.36 -1.45% RSI 39 Neutral Add Alert

Moving Averages

SMA 200

$1.58

Price below

Company Profile

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases in the United States. The company is headquartered in Waltham, Massachusetts.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$497.37M

P/E Ratio

None

EPS

$-0.3

Beta

0.738